These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 25936966

  • 1. Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update.
    Hertig A, Zuckermann A.
    Transpl Immunol; 2015 Jun; 32(3):179-87. PubMed ID: 25936966
    [Abstract] [Full Text] [Related]

  • 2. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL.
    Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
    [Abstract] [Full Text] [Related]

  • 3. Retreatment by antithymocyte globulin for second kidney transplantation: efficacy, tolerance and safety.
    Rodríguez-Reimundes E, Buron F, Chauvet C, Daoud S, Thaunat O, Brunet M, Badet L, Morelon E.
    Transpl Immunol; 2013 Jan; 28(1):6-8. PubMed ID: 23220146
    [Abstract] [Full Text] [Related]

  • 4. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL.
    Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA, Tischer SM, Lee E, Lee S, Sindelar J, Park JM.
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [Abstract] [Full Text] [Related]

  • 6. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.
    Deeks ED, Keating GM.
    Drugs; 2009 Jul 30; 69(11):1483-512. PubMed ID: 19634926
    [Abstract] [Full Text] [Related]

  • 7. Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry.
    Gaber AO, Matas AJ, Henry ML, Brennan DC, Stevens RB, Kapur S, Ilsley JN, Kistler KD, Cosimi AB, Thymoglobulin Antibody Immunosuppression in Living Donor Recipients Investigators.
    Transplantation; 2012 Aug 27; 94(4):331-7. PubMed ID: 22850297
    [Abstract] [Full Text] [Related]

  • 8. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 27; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 9. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 10. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.
    Transplant Proc; 2011 Mar 15; 43(2):458-61. PubMed ID: 21440733
    [Abstract] [Full Text] [Related]

  • 11. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 15; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 12. A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients.
    Schweiger M, Zuckermann A, Beiras-Fernandez A, Berchtolld-Herz M, Boeken U, Garbade J, Hirt S, Richter M, Ruhpawar A, Schmitto JD, Schönrath F, Schramm R, Schulz U, Wilhelm MJ, Barten MJ.
    Ann Transplant; 2018 May 15; 23():322-333. PubMed ID: 29760372
    [Abstract] [Full Text] [Related]

  • 13. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
    Devine K, Ranganathan S, Mazariegos G, Bond G, Soltys K, Ganoza A, Sun Q, Sindhi R.
    Pediatr Transplant; 2020 Aug 15; 24(5):e13723. PubMed ID: 32424963
    [Abstract] [Full Text] [Related]

  • 14. Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.
    Thrush PT, Gossett JG, Costello JM, Matthews KL, Nubani R, Bhagat H, Backer CL, Pahl E.
    Pediatr Transplant; 2014 Feb 15; 18(1):79-86. PubMed ID: 24283506
    [Abstract] [Full Text] [Related]

  • 15. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
    Cai J, Terasaki PI.
    Transplantation; 2010 Dec 27; 90(12):1511-5. PubMed ID: 21057388
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chen J, Tector AJ.
    Liver Transpl; 2012 Jul 27; 18(7):786-95. PubMed ID: 22237953
    [Abstract] [Full Text] [Related]

  • 17. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.
    Hoegh-Petersen M, Goodyear D, Geddes MN, Liu S, Ugarte-Torres A, Liu Y, Walker JT, Fonseca K, Daly A, Duggan P, Stewart D, Russell JA, Storek J.
    Bone Marrow Transplant; 2011 Aug 27; 46(8):1104-12. PubMed ID: 21057556
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 19. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 27; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 20. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation.
    Alloway RR, Woodle ES, Abramowicz D, Segev DL, Castan R, Ilsley JN, Jeschke K, Somerville KT, Brennan DC.
    Am J Transplant; 2019 Aug 27; 19(8):2252-2261. PubMed ID: 30838775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.